Tauroursodeoxycholic acid

Tauroursodeoxycholic acid is a lipid of Sterol Lipids (ST) class. Tauroursodeoxycholic acid is associated with abnormalities such as Hyperglycemia, Obesity, Wiskott-Aldrich Syndrome, neurogenic hypertension and Cholestatic liver disease. The involved functions are known as Cell Death, Apoptosis, Homeostasis, Process and mRNA Expression. Tauroursodeoxycholic acid often locates in Body tissue, Endoplasmic Reticulum, Hepatic, Blood and Protoplasm. The associated genes with Tauroursodeoxycholic acid are Homologous Gene and Mutant Proteins. The related lipids are cholanic acid, taurolithocholic acid 3-sulfate, Sterols, 7-dehydrocholesterol and tauromuricholic acid. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of Tauroursodeoxycholic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Tauroursodeoxycholic acid?

Tauroursodeoxycholic acid is suspected in Endothelial dysfunction, Hyperglycemia, Obesity, neurogenic hypertension, Cholestatic liver disease, Heart failure and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tauroursodeoxycholic acid

MeSH term MeSH ID Detail
Hypertension D006973 115 associated lipids
Insulin Resistance D007333 99 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with Tauroursodeoxycholic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Tauroursodeoxycholic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Tauroursodeoxycholic acid?

Disease model

Disease model are used in the study 'Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.' (Cortez LM et al., 2015).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Tauroursodeoxycholic acid

Download all related citations
Per page 10 20 50 100 | Total 531
Authors Title Published Journal PubMed Link
Shefer S et al. Regulation of cholesterol 7 alpha-hydroxylase by hepatic 7 alpha-hydroxylated bile acid flux and newly synthesized cholesterol supply. 1991 J. Biol. Chem. pmid:1993648
Nakai T et al. Microtubule-independent choleresis and anti-cholestatic action of tauroursodeoxycholate in colchicine-treated rat liver. 1992 Biochem. J. pmid:1361125
Häussinger D et al. Cell volume and bile acid excretion. 1992 Biochem. J. pmid:1463469
Thibault N and Ballet F Effect of bile acids on intracellular calcium in isolated rat hepatocyte couplets. 1993 Biochem. Pharmacol. pmid:8435088
Alvaro D et al. Effect of ursodeoxycholic acid on intracellular pH regulation in isolated rat bile duct epithelial cells. 1993 Am. J. Physiol. pmid:8238362
Beuers U et al. Effects of tauroursodeoxycholic acid on cytosolic Ca2+ signals in isolated rat hepatocytes. 1993 Gastroenterology pmid:8425704
Sano N et al. Estradiol-17 beta-glucuronide-induced cholestasis. Effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate. 1993 J. Hepatol. pmid:8445238
Shamburek RD and Schwartz CC Selective composition of biliary phosphatidylcholines is affected by secretion rate but not by bile acid hydrophobicity. 1993 J. Lipid Res. pmid:8263408
Beuers U et al. Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis. 1993 J. Clin. Invest. pmid:8254052
Pak JM and Lee SS Vasoactive effects of bile salts in cirrhotic rats: in vivo and in vitro studies. 1993 Hepatology pmid:8225224
Tsukahara K et al. Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats. 1993 Liver pmid:8259039
Ohiwa T et al. Tauroursodeoxycholate and tauro-beta-muricholate exert cytoprotection by reducing intrahepatocyte taurochenodeoxycholate content. 1993 Hepatology pmid:8383089
Bouchard G et al. Influence of oral treatment with ursodeoxycholic and tauroursodeoxycholic acids on estrogen-induced cholestasis in rats: effects on bile formation and liver plasma membranes. 1993 Liver pmid:8377596
Aldini R et al. Hepatic uptake and intestinal absorption of bile acids in the rabbit. 1994 Eur. J. Clin. Invest. pmid:7851470
Nguyen LB et al. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in the rat ileum: effects of bile acids and lovastatin. 1994 Metab. Clin. Exp. pmid:7968602
Kitani K et al. Tauro alpha-muricholate is as effective as tauro beta-muricholate and tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the rat. 1994 Hepatology pmid:8138240
Krähenbühl S et al. Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria. 1994 Hepatology pmid:7982660
Sakisaka S et al. Tubulovesicular transport of horseradish peroxidase in isolated rat hepatocyte couplets: effects of low temperature, cytochalasin B and bile acids. 1994 Hepatology pmid:7927203
Alvaro D et al. Functional and ultrastructural features of ethanol/bile salts interaction in the isolated perfused rat liver. 1995 Hepatology pmid:7705787
Sánchez Pozzi EJ et al. Differential effect of ursodeoxycholate and its taurine conjugate on biliary transport maximum of bilirubin in the rat. 1995 Life Sci. pmid:7643722
Groen AK et al. Regulation of protein secretion into bile: studies in mice with a disrupted mdr2 p-glycoprotein gene. 1995 Gastroenterology pmid:7498666
Rodrigues CM et al. Tauroursodeoxycholate increases rat liver ursodeoxycholate levels and limits lithocholate formation better than ursodeoxycholate. 1995 Gastroenterology pmid:7615207
Angelico M et al. N-ethyl-tauroursodeoxycholic acid, a novel deconjugation-resistant bile salt analogue: effects of acute feeding in the rat. 1995 Hepatology pmid:7657297
Ono T et al. Effect of tauroursodeoxycholic acid on bile flow and calcium excretion in ischemia-reperfusion injury of rat livers. 1995 J. Hepatol. pmid:8583148
Neuman MG et al. Effect of tauroursodeoxycholic and ursodeoxycholic acid on ethanol-induced cell injuries in the human Hep G2 cell line. 1995 Gastroenterology pmid:7615206
Takikawa H et al. Colchicine inhibits lithocholate-3-O-glucuronide-induced cholestasis in rats. 1995 J. Hepatol. pmid:7751593
Hillaire S et al. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture. 1995 Hepatology pmid:7601437
Azer SA et al. Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid. 1995 May-Jun J. Gastroenterol. Hepatol. pmid:7548801
Beuers U et al. Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. 1996 Gastroenterology pmid:8613063
Stravitz RT et al. Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7 alpha-hydroxylase. 1996 Am. J. Physiol. pmid:8770045
Muraca M et al. Protective effect of tauroursodeoxycholate against acute gastric mucosal injury induced by hydrophobic bile salts. 1996 Dig. Dis. Sci. pmid:8654150
Sugata K et al. Differential effects between tauroursodeoxycholic and taurochenodeoxycholic acids in hepatic fibrosis: an assessment by primary cultured Ito and Kupffer cells from the rat liver. 1996 J. Gastroenterol. Hepatol. pmid:8743917
Barone M et al. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies. 1996 Hepatology pmid:8621149
Albalak A et al. Effects of submicellar bile salt concentrations on biological membrane permeability to low molecular weight non-ionic solutes. 1996 Biochemistry pmid:8672496
Nebe B et al. Induction of a physical linkage between integrins and the cytoskeleton depends on intracellular calcium in an epithelial cell line. 1996 Exp. Cell Res. pmid:8940254
Groen AK et al. Control analysis of biliary lipid secretion. 1996 J. Theor. Biol. pmid:8944177
Van Erpecum KJ et al. Effects of bile salt hydrophobicity on crystallization of cholesterol in model bile. 1996 Eur. J. Clin. Invest. pmid:8864423
Heuman DM et al. Adsorption of mixtures of bile salt taurine conjugates to lecithin-cholesterol membranes: implications for bile salt toxicity and cytoprotection. 1996 J. Lipid Res. pmid:8728319
Setchell KD et al. Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis. 1996 Gut pmid:8675100
Bellentani S et al. Chronic administration of ursodeoxycholic and tauroursodeoxycholic acid changes microsomal membrane lipid content and fatty acid compositions in rats. 1996 Biochem. Biophys. Res. Commun. pmid:8607791
Crosignani A et al. Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response study. 1996 Dig. Dis. Sci. pmid:8674405
Klinkspoor JH et al. Mechanism of bile salt-induced mucin secretion by cultured dog gallbladder epithelial cells. 1996 Biochem. J. pmid:8670165
Takikawa H et al. Effects of ursodeoxycholate and its conjugates on biliary glutathione excretion in rats. 1996 Dig. Dis. Sci. pmid:8888706
Luk AS et al. Structural mechanisms of bile salt-induced growth of small unilamellar cholesterol-lecithin vesicles. 1997 Biochemistry pmid:9153403
Crocenzi FA et al. Role of bile salts in colchicine-induced hepatotoxicity. Implications for hepatocellular integrity and function. 1997 Toxicology pmid:9230445
Takikawa H et al. Absorption of unconjugated bile acids and tauroursodeoxycholate in the rat intestine. 1997 J. Gastroenterol. Hepatol. pmid:9504891
Loria P et al. Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans. 1997 Hepatology pmid:9185744
Schliess F et al. Mitogen-activated protein kinases mediate the stimulation of bile acid secretion by tauroursodeoxycholate in rat liver. 1997 Gastroenterology pmid:9322526
Meier PJ et al. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. 1997 Hepatology pmid:9398014
Ishizaki K et al. Effect of sodium tauroursodeoxycholate (UR-906) on liver dysfunction in bile duct-ligated rats. 1997 Eur. J. Pharmacol. pmid:9314037